Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

A Brief History of Shigella.

Lampel KA, Formal SB, Maurelli AT.

EcoSal Plus. 2018 Jan;8(1). doi: 10.1128/ecosalplus.ESP-0006-2017. Review.

PMID:
29318984
2.

Strategy for cross-protection among Shigella flexneri serotypes.

Noriega FR, Liao FM, Maneval DR, Ren S, Formal SB, Levine MM.

Infect Immun. 1999 Feb;67(2):782-8.

4.

Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes.

Noriega FR, Liao FM, Formal SB, Fasano A, Levine MM.

J Infect Dis. 1995 Nov;172(5):1408-10.

PMID:
7594690
5.

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.

Kotloff KL, Losonsky GA, Nataro JP, Wasserman SS, Hale TL, Taylor DN, Newland JW, Sadoff JC, Formal SB, Levine MM.

Vaccine. 1995 Apr;13(5):495-502.

PMID:
7639017
6.

Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2.

Taylor DN, Phillip DF, Zapor M, Trofa A, Van de Verg L, Hartman A, Bendiuk N, Newland JW, Formal SB, Sadoff JC, et al.

Vaccine. 1994 May;12(6):565-8.

PMID:
8036831
7.

Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.

Kotloff KL, Herrington DA, Hale TL, Newland JW, Van De Verg L, Cogan JP, Snoy PJ, Sadoff JC, Formal SB, Levine MM.

Infect Immun. 1992 Jun;60(6):2218-24.

9.

Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.

Formal SB, Oaks EV, Olsen RE, Wingfield-Eggleston M, Snoy PJ, Cogan JP.

J Infect Dis. 1991 Sep;164(3):533-7.

PMID:
1869840
10.

Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain.

Venkatesan M, Fernandez-Prada C, Buysse JM, Formal SB, Hale TL.

Vaccine. 1991 May;9(5):358-63.

PMID:
1872021
11.

An O antigen can interfere with the function of the Yersinia pseudotuberculosis invasin protein.

Voorhis DL, Dillon S, Formal SB, Isberg RR.

Mol Microbiol. 1991 Feb;5(2):317-25.

PMID:
1710312
12.
14.
15.

Inoculum size in shigellosis and implications for expected mode of transmission.

DuPont HL, Levine MM, Hornick RB, Formal SB.

J Infect Dis. 1989 Jun;159(6):1126-8. No abstract available.

PMID:
2656880
16.

Shigella vaccines.

Formal SB, Hale TL, Kapfer C.

Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S547-51. Review.

PMID:
2669098
17.

Electrolyte transport in rabbit cecum. I. Effect of RDEC-1 infection.

Tai YH, Gage TP, McQueen C, Formal SB, Boedeker EC.

Am J Physiol. 1989 Apr;256(4 Pt 1):G721-6.

PMID:
2539738
18.
19.

Intracellular spread of Shigella flexneri associated with the kcpA locus and a 140-kilodalton protein.

Pál T, Newland JW, Tall BD, Formal SB, Hale TL.

Infect Immun. 1989 Feb;57(2):477-86.

20.

Oral shigella vaccines.

Hale TL, Formal SB.

Curr Top Microbiol Immunol. 1989;146:205-11. Review. No abstract available.

PMID:
2659269
21.

Recurrent shigellosis complicating human immunodeficiency virus infection: failure of pre-existing antibodies to confer protection.

Blaser MJ, Hale TL, Formal SB.

Am J Med. 1989 Jan;86(1):105-7. No abstract available.

PMID:
2642653
22.

Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence.

Neill RJ, Gemski P, Formal SB, Newland JW.

J Infect Dis. 1988 Oct;158(4):737-41.

PMID:
3049838
23.

Pathogenesis, genetics of virulence, and immunity in Shigellosis.

Formal SB, Kapfer C, Hale TL.

Kansenshogaku Zasshi. 1988 Mar;62 Suppl:329-42. Review. No abstract available.

PMID:
3138359
24.

Association of pathogens with the intestinal mucosa and the design of vaccines.

Formal SB, Hale TL, Kapfer C.

Monogr Allergy. 1988;24:46-50. No abstract available.

PMID:
3283533
25.

Introduction of Shigella flexneri 2a type and group antigen genes into oral typhoid vaccine strain Salmonella typhi Ty21a.

Baron LS, Kopecko DJ, Formal SB, Seid R, Guerry P, Powell C.

Infect Immun. 1987 Nov;55(11):2797-801.

26.

Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.

Black RE, Levine MM, Clements ML, Losonsky G, Herrington D, Berman S, Formal SB.

J Infect Dis. 1987 Jun;155(6):1260-5.

PMID:
2437220
27.

Local and systemic antibody responses to Shigella infection in rhesus monkeys.

Dinari G, Hale TL, Austin SW, Formal SB.

J Infect Dis. 1987 May;155(5):1065-9. No abstract available.

PMID:
3549918
28.

Pathogenesis of Shigella infections.

Hale TL, Formal SB.

Pathol Immunopathol Res. 1987;6(2):117-27. Review. No abstract available.

PMID:
3321018
30.

Genetics of virulence in Shigella.

Hale TL, Formal SB.

Microb Pathog. 1986 Dec;1(6):511-8. Review. No abstract available.

PMID:
3334157
32.

Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine.

Keenan KP, Sharpnack DD, Collins H, Formal SB, O'Brien AD.

Am J Pathol. 1986 Oct;125(1):69-80.

33.
34.
37.

Plaque formation by virulent Shigella flexneri.

Oaks EV, Wingfield ME, Formal SB.

Infect Immun. 1985 Apr;48(1):124-9.

38.

Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.

O'Brien AD, Newland JW, Miller SF, Holmes RK, Smith HW, Formal SB.

Science. 1984 Nov 9;226(4675):694-6.

PMID:
6387911
39.

Expression of lipopolysaccharide O antigen in Escherichia coli K-12 hybrids containing plasmid and chromosomal genes from Shigella dysenteriae 1.

Hale TL, Guerry P, Seid RC Jr, Kapfer C, Wingfield ME, Reaves CB, Baron LS, Formal SB.

Infect Immun. 1984 Nov;46(2):470-5.

40.

Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.

Formal SB, Hale TL, Kapfer C, Cogan JP, Snoy PJ, Chung R, Wingfield ME, Elisberg BL, Baron LS.

Infect Immun. 1984 Nov;46(2):465-9.

41.

Plasmids and the virulence of enteric and other bacterial pathogens.

Kopecko DJ, Formal SB.

Ann Intern Med. 1984 Aug;101(2):260-2. No abstract available.

PMID:
6378008
42.

Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen.

Seid RC Jr, Kopecko DJ, Sadoff JC, Schneider H, Baron LS, Formal SB.

J Biol Chem. 1984 Jul 25;259(14):9028-34.

43.

Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).

Tramont EC, Chung R, Berman S, Keren D, Kapfer C, Formal SB.

J Infect Dis. 1984 Feb;149(2):133-6.

PMID:
6366077
44.

Invasive enteric pathogens.

Formal SB, Hale TL, Sansonetti PJ.

Rev Infect Dis. 1983 Sep-Oct;5 Suppl 4:S702-7. Review.

PMID:
6356290
45.
47.

Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin.

O'Brien AO, Lively TA, Chen ME, Rothman SW, Formal SB.

Lancet. 1983 Mar 26;1(8326 Pt 1):702. No abstract available.

PMID:
6132054
48.

Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri.

Sansonetti PJ, Hale TL, Dammin GJ, Kapfer C, Collins HH Jr, Formal SB.

Infect Immun. 1983 Mar;39(3):1392-402.

49.

Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.

O'Brien AD, LaVeck GD, Thompson MR, Formal SB.

J Infect Dis. 1982 Dec;146(6):763-9.

PMID:
6754826
50.

Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmid.

Keren DF, Collins HH, Baron LS, Kopecko DJ, Formal SB.

Infect Immun. 1982 Jul;37(1):387-9.

Supplemental Content

Loading ...
Support Center